Headline News about Gsk Plc ADR![]()
GSK's Rare Blood Cancer Candidate Goes Under FDA Review
August 17, 2022
Via Benzinga
![]()
One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK
August 17, 2022
Via Benzinga
![]()
Why IDEAYA Biosciences Shares Plunging Today
August 15, 2022
Via Benzinga
![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]()
Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy
August 09, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() Via Benzinga
![]()
IDEAYA's Cancer Candidate Shows Early Tumor Modulation
July 27, 2022
Via Benzinga
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|